Table: begin end state 1 26 cytoplasmic 27 52 transmembrane 53 59 non-cytoplasmic 60 80 transmembrane 81 91 cytoplasmic 92 113 transmembrane 114 159 non-cytoplasmic 160 183 transmembrane 184 194 cytoplasmic 195 215 transmembrane 216 244 non-cytoplasmic 245 265 transmembrane 266 284 cytoplasmic 285 310 transmembrane 311 329 non-cytoplasmic 330 352 transmembrane 353 382 cytoplasmic 383 402 transmembrane 403 407 non-cytoplasmic 408 427 transmembrane 428 438 cytoplasmic 439 460 transmembrane 461 465 non-cytoplasmic 466 483 transmembrane 484 495 cytoplasmic
Input: >NP_661816.1 NCBI__GCF_000006985.1:NP_661816.1 MKNSFRKKPLSLLLEEMKSEHRLNRVLGPLALTSLGVGAIIGTGIFVLIGVAAHDKAGPA VTLSFALAGLACVFAALCYAEFASMAPVAGSAYTYAYATLGELFAWIIGWDLILEYAVAS ATVAHGWSHYFQDFMGIFGLHIPEIFSRAPLDFDPATGSLVLTGSMFDLPAVIIVLIVTV ILVKGIRESAGFNTAMVIVKVAIVLLVIVLGAQYVKPENWQPFAPFGYSGLSVFGHTILG ETGAGGAPVGVLAGAAMIFFAYIGFDSISTHAEEARRPERDVPIGIIASLIICTMLYVAV AAVITGMVPYDQINIDAPVSYAFKQVGLDWAQFLVSLGAITGITSVLLVMMLSQPRIFLA MARDGLLPNKFFGVVHPKFKTPWNATILTGIFVAILGAFLPLRLLAELVNIGTLFAFVVV CAAVLIMRRTNPDAERPFRAPLVPFVPIAGILTCLLLMFSLPAENWWRLIVWLLIGFCIY FFYGRHHSVLNQHHD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server